New gel scaffold aims to improve healing after skin cancer removal
NCT ID NCT06600152
First seen Jun 05, 2026 · Last updated Jun 22, 2026 · Updated 3 times
Summary
This study tested a new gel-like wound dressing called MAP Wound Matrix (TT101) in 40 adults who had skin cancer removed with Mohs surgery. The dressing was applied right after surgery to see if it was safe and helped wounds heal compared to a standard hydrocolloid bandage. The main goal was to check for serious side effects like infections or slow healing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cal Coast Dermatology
Encino, California, 91436, United States
-
Laser and Skin Surgery Center of Indiana
Indianapolis, Indiana, 46260, United States
-
Studies in Dermatology
Cypress, Texas, 77429, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MAP Wound Matrix (a gel-like scaffold applied to the wound)
What this could lead to
If it works, this could offer a new option to help wounds heal better after skin cancer surgery, potentially reducing complications.
What could go wrong
This is a small, early safety study with only 40 people. The new matrix may not heal wounds better than standard dressings, and there is a risk of infection or delayed healing.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.